Similar articles

• Thymosin for immunodeficiency diseases and cancer.

  Goldstein AL, Rossio JL. Goldstein AL, et al. Compr Ther. 1978 Feb;4(2):49-57. Compr Ther. 1978. PMID: 624213 No abstract available.
• Thymosin treatment of children with primary immunodeficiency disease.

  Wara DW, Ammann AJ. Wara DW, et al. Transplant Proc. 1978 Mar;10(1):203-9. Transplant Proc. 1978. PMID: 305674 No abstract available.
• [Regular trisomy 21 and combined immunodeficiency. Ineffectiveness of thymosin].

  Calvani M, Aiuti F, Felici N, D'Amelio R, Picchio E. Calvani M, et al. Minerva Pediatr. 1979 Dec 15;31(23):1691-7. Minerva Pediatr. 1979. PMID: 162325 Italian. No abstract available.
• Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.

  Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
• Thymosin and the endocrine thymus.

  Schulof RS, Goldstein AL. Schulof RS, et al. Adv Intern Med. 1977;22:121-43. Adv Intern Med. 1977. PMID: 320839 Review. No abstract available.